Marcello Damiani
Director/Board Member at Cellarity Inc.
Marcello Damiani active positions
| Companies | Position | Start | End |
|---|---|---|---|
ModernaTX, Inc.
 ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
Cellarity Inc.
 Cellarity Inc. BiotechnologyHealth Technology Cellarity Inc. engages in the operation of platform to design medicines targeting the full cellular and molecular complexity of disease. The company was founded by Avak Kahvejian, James J. Collins, Noubar Afeyan, and Nicholas Plugis in 2017 and is headquartered in Cambridge, MA. | Director/Board Member | 01/01/2019 | - |
Career history of Marcello Damiani
Former positions of Marcello Damiani
| Companies | Position | Start | End |
|---|---|---|---|
| BENEVOLENTAI | Director/Board Member | 04/05/2023 | 02/05/2024 |
| Independent Dir/Board Member | 04/05/2023 | 02/05/2024 | |
| MODERNA, INC. | Corporate Officer/Principal | 01/09/2018 | 01/01/2022 |
| BIOMÉRIEUX | Chief Tech/Sci/R&D Officer | 01/01/2009 | 01/01/2015 |
Training of Marcello Damiani
| Trium Global Emba | Masters Business Admin |
| Institut d'Administration Des Entreprises De Toulouse | Graduate Degree |
Statistics
International
| United States | 4 |
| France | 3 |
| Luxembourg | 2 |
Operational
| Corporate Officer/Principal | 2 |
| Director/Board Member | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| MODERNA, INC. | Health Technology |
| BIOMÉRIEUX | Health Technology |
| BENEVOLENTAI | Health Technology |
| Private companies | 2 |
|---|---|
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | Health Technology |
Cellarity Inc.
Cellarity Inc. BiotechnologyHealth Technology Cellarity Inc. engages in the operation of platform to design medicines targeting the full cellular and molecular complexity of disease. The company was founded by Avak Kahvejian, James J. Collins, Noubar Afeyan, and Nicholas Plugis in 2017 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Marcello Damiani
- Experience
